tiprankstipranks
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
US Market

FibroBiologics, Inc. (FBLG) Income Statement

19 Followers

FibroBiologics, Inc. Income Statement

Last quarter (Q ), FibroBiologics, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q, FibroBiologics, Inc.'s net income was $―. See FibroBiologics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
-$ 8.89M$ 4.47M
Operating Income
-$ -8.89M$ -4.47M
Net Non Operating Interest Income Expense
-$ -147.00K$ -654.00K
Other Income Expense
-$ 213.00K-
Pretax Income
-$ -9.25M$ -5.12M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
-$ -19.06M$ -5.12M
Basic EPS
-$ -0.68$ -0.18
Diluted EPS
-$ -0.68$ -0.18
Basic Average Shares
-$ 28.23M$ 28.23M
Diluted Average Shares
-$ 28.23M$ 28.23M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
-$ 8.89M$ 4.47M
Net Income From Continuing And Discontinued Operation
-$ -16.48M$ -5.12M
Normalized Income
---
Interest Expense
---
EBIT
-$ -9.10M-
EBITDA
-$ -8.58M-
Currency in USD

FibroBiologics, Inc. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis